CBD of Denver Inc.
CBDD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,754 | $2,982 | $2,344 | $22,851 |
| % Growth | 25.9% | 27.2% | -89.7% | – |
| Cost of Goods Sold | $3,536 | $2,816 | $3,014 | $22,610 |
| Gross Profit | $218 | $165 | -$670 | $241 |
| % Margin | 5.8% | 5.5% | -28.6% | 1.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $144 | $429 | $2,078 | $566 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $144 | $429 | $2,078 | $566 |
| Operating Income | $74 | -$264 | -$2,747 | -$326 |
| % Margin | 2% | -8.9% | -117.2% | -1.4% |
| Other Income/Exp. Net | -$153 | $848 | -$510 | $22 |
| Pre-Tax Income | -$78 | $584 | -$3,257 | -$304 |
| Tax Expense | $2 | $0 | -$6 | -$68 |
| Net Income | -$80 | $584 | -$3,251 | -$236 |
| % Margin | -2.1% | 19.6% | -138.7% | -1% |
| EPS | 0 | 0 | -0.001 | 0 |
| % Growth | -100% | 116.7% | – | – |
| EPS Diluted | 0 | 0 | -0.001 | 0 |
| Weighted Avg Shares Out | 7,289,089 | 6,382,180 | 5,696,732 | 5,250,405 |
| Weighted Avg Shares Out Dil | 7,289,089 | 6,382,180 | 5,696,732 | 5,250,405 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $153 | $114 | $3 | $5 |
| Depreciation & Amortization | $11 | $168 | $228 | $237 |
| EBITDA | $85 | $866 | -$3,026 | -$63 |
| % Margin | 2.3% | 29% | -129.1% | -0.3% |